Clinical practice guidelines for the management of atopic dermatitis 2018
- PMID: 31599013
- DOI: 10.1111/1346-8138.15090
Clinical practice guidelines for the management of atopic dermatitis 2018
Abstract
Atopic dermatitis (AD) is a disease characterized by relapsing eczema with pruritus as a primary lesion. The current strategies to treat AD in Japan from the perspective of evidence-based medicine consist of three primary measures: (i) the use of topical corticosteroids and tacrolimus ointment as the main treatment for the inflammation; (ii) topical application of emollients to treat the cutaneous barrier dysfunction; and (iii) avoidance of apparent exacerbating factors, psychological counseling and advice about daily life. The guidelines present recommendations to review clinical research articles, evaluate the balance between the advantages and disadvantages of medical activities, and optimize medical activity-related patient outcomes with respect to several important points requiring decision-making in clinical practice.
Keywords: atopic dermatitis; clinical practice guidelines; clinical questions; evidence-based medicine; treatment.
© 2019 Japanese Dermatological Association.
References
-
- Kawashima M, Takigawa M, Nakagawa H et al. Guidelines for management of atopic dermatitis. Jpn J Dermatol 2000; 110: 1099-1104.
-
- Furue M, Furukawa F, Hide M, Takehara K, Japanese Dermatological Association. Guidelines for therapy for atopic dermatitis 2003. Jpn J Dermatol 2003; 113: 451-457.
-
- Furue M, Furukawa F, Hide M, Takehara K. Japanese Dermatological Association Guidelines for therapy of atopic dermatitis 2004. Jpn J Dermatol 2004; 114: 135-142.
-
- Furue M, Saeki H, Furukawa F et al. Guidelines for therapy of atopic dermatitis. Jpn J Dermatol 2008; 118: 325-342.
-
- Furue M, Saeki H, Furukawa F et al. Guidelines for therapy of atopic dermatitis. Jpn J Dermatol 2009; 119: 1515-1534.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
